Clinical recommendations on lung cancer management during the COVID‐19 pandemic

Coronavirus disease 2019 (COVID‐19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yan, Liu, Hongsheng, Hu, Ke, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Clinical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283707/
https://www.ncbi.nlm.nih.gov/pubmed/32469164
http://dx.doi.org/10.1111/1759-7714.13498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283707/
https://www.ncbi.nlm.nih.gov/pubmed/32469164
http://dx.doi.org/10.1111/1759-7714.13498

Ejemplares similares